June 9, 2020 / 1:43 AM / a month ago

BRIEF-Alphamab Oncology Says Strategic Collaboration With Sanofi On Kn026 In Her2+ Breast Cancer

June 9 (Reuters) - Alphamab Oncology:

* STRATEGIC COLLABORATION WITH SANOFI ON KN026 IN HER2+ BREAST CANCER

* UNITS OF CO, SANOFI ENTERED EXCLUSIVE OPTION DEAL FOR STUDIES ON KN026 WITH TAXOTERE IN PATIENTS WITH HER2-POSITIVE BREAST CANCER Source text bit.ly/2UoJgpo Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below